Regeneron Pharmaceuticals reported $9.47 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 9.47 9.13 8.22 Apr/29
FY2025Q4 Dec/2025 11.44 10.61 12.07 Jan/30
FY2025Q3 Sep/2025 11.83 9.67 12.46 Oct/28
FY2025Q2 Jun/2025 12.89 8.60 11.56 Aug/01
FY2025Q1 Mar/2025 8.22 9.55 9.55 Apr/29




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Agenus USD -0.3 0.84 Dec/2025
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Astellas Pharma JPY 24.29 31.75 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Kyowa Hakko Kirin JPY 22.99 42.8 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Novartis USD 1.99 0.45 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 2.17 2.84 Mar/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Teva Pharmaceutical Industries USD 1.57 1.41 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026